A Whole-Genome SNP Association Study of NCI60 Cell Line Panel Indicates a Role of Ca2+ Signaling in Selenium Resistance

Epidemiological studies have suggested an association between selenium intake and protection from a variety of cancer. Considering this clinical importance of selenium, we aimed to identify the genes associated with resistance to selenium treatment. We have applied a previous methodology developed by our group, which is based on the genetic and pharmacological data publicly available for the NCI60 cancer cell line panel. In short, we have categorized the NCI60 cell lines as selenium resistant and sensitive based on their growth inhibition (GI50) data. Then, we have utilized the Affymetrix 125K SNP chip data available and carried out a genome-wide case-control association study for the selenium sensitive and resistant NCI60 cell lines. Our results showed statistically significant association of four SNPs in 5q33–34, 10q11.2, 10q22.3 and 14q13.1 with selenium resistance. These SNPs were located in introns of the genes encoding for a kinase-scaffolding protein (AKAP6), a membrane protein (SGCD), a channel protein (KCNMA1), and a protein kinase (PRKG1). The knock-down of KCNMA1 by siRNA showed increased sensitivity to selenium in both LNCaP and PC3 cell lines. Furthermore, SNP-SNP interaction (epistasis) analysis indicated the interactions of the SNPs in AKAP6 with SGCD as well as SNPs in AKAP6 with KCNMA1 with each other, assuming additive genetic model. These genes were also all involved in the Ca2+ signaling, which has a direct role in induction of apoptosis and induction of apoptosis in tumor cells is consistent with the chemopreventive action of selenium. Once our findings are further validated, this knowledge can be translated into clinics where individuals who can benefit from the chemopreventive characteristics of the selenium supplementation will be easily identified using a simple DNA analysis

Physiological compartmental modeling of total lycopene metabolism and its cis/trans isomers in humans.

Physiological compartmental modeling of total lycopene metabolism and its cis/trans isomers in humans

Informe final programa Ejercicio Profesional Supervisado en el hospital departamental de Sololá, Sololá. Junio 2015 – junio 2016.

Prevención de enfermedades bucales Se impartieron pláticas semanales sobre diversos temas en salud bucal. Durante los 8 meses de duración del EPS se impartieron un total de 62. Barrido de sellantes de fosas y fisuras: En la cual se sellaron las piezas permanentes eruptadas y primarias, que se encontraban sin lesión de caries, cubriendo un total de 818 piezas selladas. Enjuagatorios de fluoruro de sodio al 0.2% semanal en el que se cubrieron dos escuelas EOUM Justo Rufino Barrios (Matutina y Vespertina) y el Centro Estudiantil Jesucristo, con un total de 800 niños al mes, los primeros cuatro meses; y 1180 en la segunda parte del programa. Al finalizar el programa se realizó un total de 31,680 enjuagatorios. Actividad clínica integrada Se atendió al finalizar el programa 122 pacientes integrales y se realizaron 110 profilaxis bucales y aplicaciones tópicas de flúor, 29 detartrajes, 5 restauraciones de ionómero de vidrio, 420 restauraciones de amalgama, 686 restauraciones de resina, 818 sellantes de fosas y fisuras, 5 coronas de acero, 151 extracciones dentales, 1 pulpotomía, 1 pulpectomía. Administración del consultorio “El estudiante debe planificar, organizar, desarrollar y evaluar la administración de la clínica dental que se le haya asignado para la realización del programa EPS, siguiendo las normas establecidas para esta actividad.” En este subprograma se incluye todo lo relacionado con la asistencia y puntualidad, presentación personal, administración de la clínica dental (libro de citas, archivo y fichas clínicas) y la capacitación del personal auxiliar, así como, protocolo de desinfección y esterilización tanto del odontólogo como del personal auxiliar, instrumental y clínica dental

Selenoprotein deficiency accelerates prostate carcinogenesis in a transgenic model

Considerable animal and human data have indicated that selenium is effective in reducing the incidence of several different types of cancer, including that of the prostate. However, the mechanism by which selenium inhibits carcinogenesis remains unknown. One possibility is that dietary selenium influences the levels of selenium-containing proteins, or selenoproteins. Selenoproteins contain selenium in the form of selenocysteine and perform a variety of cellular functions, including antioxidant defense. To determine whether the levels of selenoproteins can influence carcinogenesis independent of selenium intake, a unique mouse model was developed by breeding two transgenic animals: mice with reduced selenoprotein levels because of the expression of an altered selenocysteine-tRNA (i(6)A(−)) and mice that develop prostate cancer because of the targeted expression of the SV40 large T and small t oncogenes to that organ [C3(1)/Tag]. The resulting bigenic animals (i(6)A(−)/Tag) and control WT/Tag mice were assessed for the presence, degree, and progression of prostatic epithelial hyperplasia and nuclear atypia. The selenoprotein-deficient mice exhibited accelerated development of lesions associated with prostate cancer progression, implicating selenoproteins in cancer risk and development and raising the possibility that selenium prevents cancer by modulating the levels of these selenoproteins